Report Addresses Challenges in Implementing New Diagnostic Tests Where They Are Needed Most
WASHINGTON, DC – June 8, 2012 – Easy-to-use, inexpensive tests to diagnose infectious diseases are urgently needed in resource-limited countries. A new report based on an American Academy of Microbiology colloquium, Bringing the Lab to the Patient: Developing Point-of-Care Diagnostics for Resource Limited Settings describes the challenges inherent in bringing new medical devices and technologies to the areas of the world where they are needed most.
Honoring the fundamental role of microbes in the natural history of our planet
WASHINGTON, DC – May 30, 2012 – Inspired by a 2009 colloquium on microbial evolution convened at the Galapagos Islands, a new book from ASM Press, Microbes and Evolution: The World That Darwin Never Saw celebrates Charles Darwin and his landmark publication On the Origin of Species. The editors compiled 40 first-person essays, written by microbiologists with a passion for evolutionary biology, to illuminate how each scientist’s thinking and career paths in science were influenced by Darwin’s seminal work.
Antibiotics Boost Risk of Infection with Antifungal-Resistant Candida
Previous exposure to certain antibiotics could boost the risk of infection with drug-resistant strains of a severe fungal infection. Researchers report their findings in the May 2012 issue of the journal Antimicrobial Agents and Chemotherapy.
How one strain of MRSA becomes resistant to last-line antibiotic
WASHINGTON, DC – May 22, 2012 – Researchers have uncovered what makes one particular strain of methicillin-resistant Staphylococcus aureus (MRSA) so proficient at picking up resistance genes, such as the one that makes it resistant to vancomycin, the last line of defense for hospital-acquired infections. They report their findings in mBio®, the online open-access journal of the American Society for Microbiology, on Tuesday May 22.Save
Experimental Vaccine Elicits Robust Response Against Both HIV and Tuberculosis
Clinician researchers in China have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis (Mtb). An estimated 14 million people worldwide are coinfected with the two pathogens. The research is published in the May 2012 issue of Clinical and Vaccine Immunology.